Subscribe to RSS
DOI: 10.1055/s-0040-1721857
The Effectiveness of Melissa Officinalis L. versus Citalopram on Quality of Life of Menopausal Women with Sleep Disorder: A Randomized Double-Blind Clinical Trial
Abstract
Objective The present study aimed to assess the effect of Melissa Officinalis L. (a combination of lemon balm with fennel fruit extract) compared with citalopram and placebo on the quality of life of postmenopausal women with sleep disturbance.
Methods The present study is a randomized, double-blind, placebo clinical trial among 60 postmenopausal women with sleep disturbance who were referred to a university hospital from 2017 to 2019. The participants were randomized to receive M. Officinalis L. (500 mg daily), citalopram (30 mg) or placebo once daily for 8 weeks. The Menopause-Specific Quality of Life (MENQOL) questionnaire was self-completed by each participant at baseline and after 8 weeks of the intervention and was compared between groups.
Results The mean for all MENQOL domain scores were significantly improved in the M. Officinalis L. group compared with citalopram and placebo (p < 0.001). The mean ± standard deviation (SD) after 8 weeks in the M. Officinalis L., citalopram and placebo groups was 2.2 ± 0.84 versus 0.56 ± 0.58 versus 0.36 ± 0.55 in the vasomotor (p < 0.001), 1.02 ± 0.6 versus 0.28 ± 0.2 versus 0.17 ± 0.1 in the psychomotor-social (p < 0.001), 0.76 ± 0.4 versus 0.25 ± 0.1 versus 0.11 ± 0.1 in the physical and 2.3 ± 1.0 versus 0.35 ± 0.5 versus 0.41 ± 0.5 in the sexual domain, respectively.
Conclusions The results revealed that M. Officinalis L. may be recommended for improving the quality of life of menopausal women with sleep disturbance.
Trial registration The present study was registered by the name “Comparison of the efficacy of citalopram and compound of Asperugo procumbens and foeniculum vulgare in treatment of menopausal disorders” with the code IRCT2013072714174N1 in the Iranian Registry of Clinical Trials (IRCT).
Contributions
Shirazi M: study conception and design, analysis and interpretation of data, critical revision; Jalalian M. N.: analysis and interpretation of data; Abed M.: drafting of the manuscript; Ghaemi M: analysis and interpretation of data, critical revision. All authors have read and approved the manuscript.
Publication History
Received: 06 February 2020
Accepted: 23 October 2020
Article published online:
19 January 2021
© 2021. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999; 353 (9152): 571-580 DOI: 10.1016/S0140-6736(98)0552-5.
- 2 Gibbs RS, Karlan BY, Haney AF, Nygaard IE. Danforth's obstetrics and gynecology. 10th ed.. Philadelphia: Lippincott Williams & Wilkins; 2008
- 3 Freedman RR. Menopause and sleep. Menopause 2014; 21 (05) 534-535 DOI: 10.1097/GME.0000000000000243.
- 4 Krystal AD, Edinger J, Wohlgemuth W, Marsh GR. Sleep in peri-menopausal and post-menopausal women. Sleep Med Rev 1998; 2 (04) 243-253 DOI: 10.1016/s1087-0792(98)90011-9.
- 5 Baker FC, Lampio L, Saaresranta T, Polo-Kantola P. Sleep and sleep disorders in the menopausal transition. Sleep Med Clin 2018; 13 (03) 443-456 DOI: 10.1016/j.jsmc.2018.04.011.
- 6 Steels E, Steele ML, Harold M, Coulson S. Efficacy of a proprietary Trigonella foenum-graecum L. de-husked seed extract in reducing menopausal symptoms in otherwise healthy women: a double-blind, randomized, placebo-controlled study. Phytother Res 2017; 31 (09) 1316-1322 DOI: 10.1002/ptr.5856.
- 7 Johnson A, Roberts L, Elkins G. Complementary and alternative medicine for menopause. J Evid Based Integr Med 2019; 24: X19829380 DOI: 10.1177/2515690X19829380.
- 8 Kennedy DO, Little W, Haskell CF, Scholey AB. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res 2006; 20 (02) 96-102 DOI: 10.1002/ptr.1787.
- 9 Ranjbar M, Firoozabadi A, Salehi A, Ghorbanifar Z, Zarshenas MM, Sadeghniiat-Haghighi K, Rezaizadeh H. Effects of Herbal combination (Melissa officinalis L. and Nepeta menthoides Boiss. & Buhse) on insomnia severity, anxiety and depression in insomniacs: Randomized placebo controlled trial. Integr Med Res 2018; 7 (04) 328-332 DOI: 10.1016/j.imr.2018.08.001.
- 10 Miraj S, , Rafieian-Kopaei, Kiani S. Melissa officinalis L: a review study with an antioxidant prospective. J Evid Based Complementary Altern Med 2017; 22 (03) 385-394 DOI: 10.1177/2156587216663433.
- 11 Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L. - A review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol 2016; 188: 204-228 DOI: 10.1016/j.jep.2016.05.010.
- 12 Nazifi M, Mokarami H, Akbaritabar A, Kalte HO, Rahi A. Psychometric properties of the Persian translation of Pittsburgh sleep quality index. Health Scope. 2014; 3 (02) e15547 DOI: 10.17795/jhealthscope-15547.
- 13 Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas 2005; 50 (03) 209-221 DOI: 10.1016/j.maturitas.2004.06.015.
- 14 Ghazanfarpour M, Kaviani M, Rezaiee M, Ghaderi E, Zandvakili F. Cross cultural adaptation of the menopause specific questionnaire into the persian language. Ann Med Health Sci Res 2014; 4 (03) 325-329 DOI: 10.4103/2141-9248.133453.
- 15 Lee J, Han Y, Cho HH, Kim MR. Sleep disorders and menopause. J Menopausal Med 2019; 25 (02) 83-87 DOI: 10.6118/jmm.19192.
- 16 Ensrud KE, Joffe H, Guthrie KA, Larson JC, Reed SD, Newton KM. et al. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial. Menopause 2012; 19 (08) 848-855 DOI: 10.1097/gme.0b013e3182476099.
- 17 Baldwin DS, Reines EH, Guiton C, Weiller E. Escitalopram therapy for major depression and anxiety disorders. Ann Pharmacother 2007; 41 (10) 1583-1592 DOI: 10.1345/aph.1K089.
- 18 Qaseem A, Snow V, Denberg TD, Forciea MA, Owens DK. Clinical Efficacy Assessment Subcommittee of American College of Physicians. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008; 149 (10) 725-733 DOI: 10.7326/0003-4819-149-10-200811180-00007.
- 19 Welz AN, Emberger-Klein A, Menrad K. Why people use herbal medicine: insights from a focus-group study in Germany. BMC Complement Altern Med 2018; 18 (01) 92 DOI: 10.1186/s12906-018-2160-6.
- 20 Cases J, Ibarra A, Feuillère N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Med J Nutrition Metab 2011; 4 (03) 211-218 DOI: 10.1007/s12349-010-0045-4.
- 21 Shirazi M, Saedi N, Shariat M, Azadi F, Davari Tanha F. Comparison of melissa with citalopram and placebo in treatment of sleep disorders in menopausal women: clinical trial. Tehran Univ Med J 2016; 74 (08) 562-568
- 22 Taavoni S, Nazem Ekbatani N, Haghani H. Valerian/lemon balm use for sleep disorders during menopause. Complement Ther Clin Pract 2013; 19 (04) 193-196 DOI: 10.1016/j.ctcp.2013.07.002.
- 23 Taiwo AE, Leite FB, Lucena GM. et al. Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: Influence of administration and gender. Indian J Pharmacol 2012; 44 (02) 189-192 DOI: 10.4103/0253-7613.93846.
- 24 Ibarra A, Feuillere N, Roller M, Lesburgere E, Beracochea D. Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine 2010; 17 (06) 397-403 DOI: 10.1016/j.phymed.2010.01.012.
- 25 Kennedy DO, Little W, Scholey AB. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom Med 2004; 66 (04) 607-613 DOI: 10.1097/01.psy.0000132877.72833.71.
- 26 Noguchi-Shinohara M, Ono K, Hamaguchi T, Iwasa K, Nagai T, Kobayashi S. et al. Pharmacokinetics, safety and tolerability of Melissa officinalis extract which contained rosmarinic acid in healthy individuals: a randomized controlled trial. PLoS One 2015; 10 (05) e0126422 DOI: 10.1371/journal.pone.0126422.
- 27 Whiteley J, DiBonaventura Md, Wagner JS, Alvir J, Shah S. The impact of menopausal symptoms on quality of life, productivity, and economic outcomes. J Womens Health (Larchmt) 2013; 22 (11) 983-990 DOI: 10.1089/jwh.2012.3719.
- 28 Barak Y, Swartz M, Levy D, Weizman R. Age-related differences in the side effect profile of citalopram. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27 (03) 545-548 DOI: 10.1016/S0278-5846(03)00041-1.
- 29 Estevinho MM, Afonso J, Rosa I, Lago P, Trindade E, Correia L. et al; GEDII [Portuguese IBD Group]. Placebo effect on the health-related quality of life of inflammatory bowel disease patients: a systematic review with meta-analysis. J Crohn's Colitis 2018; 12 (10) 1232-1244 DOI: 10.1093/ecco-jcc/jjy100.
- 30 Ghazanfarpour M, Mohammadzadeh F, Shokrollahi P, Khadivzadeh T, Najafi MN, Hajirezaee H, Afiat M. Effect of Foeniculum vulgare (fennel) on symptoms of depression and anxiety in postmenopausal women: a double-blind randomised controlled trial. J Obstet Gynaecol 2018; 38 (01) 121-126 DOI: 10.1080/01443615.2017.1342229.